Septic arthritis – symptoms, diagnosis and new therapy Angelika DomagałaBarbara MacuraAneta Kiecka Review 18 February 2025 Pages: 1019 - 1029
Rapid diagnosis of urinary tract infection with miniaturised point-of-care cultivation on a dipstick Emre IseriGino JakobssonAlex van Belkum Review 10 March 2025 Pages: 1031 - 1040
In vitro activity and resistance mechanisms of novel antimicrobial agents against metallo-β-lactamase producers Matteo BoattiniPaolo GaibaniGabriele Bianco Review Open access 10 March 2025 Pages: 1041 - 1068
Regional distribution of carbapenemase-producing Acinetobacter baumannii isolates in southern Spain (Andalusia) Felipe Fernández-CuencaSalud Rodríguez-PallaresAlvaro Pascual Research Open access 17 February 2025 Pages: 1069 - 1076
Addressing carbapenemase-producing extensively drug-resistant Pseudomonas aeruginosa: the potential of cefiderocol and ceftazidime/avibactam plus aztreonam therapy María Milagro MonteroSandra Domene-OchoaJuan P. Horcajada Research Open access 18 February 2025 Pages: 1077 - 1087
In vitro synergistic effects of mefloquine combined with other antimicrobial agents on carbapenem-resistant Enterobacterales Chunhong ZouZixin WenSiqiang Niu Research 18 February 2025 Pages: 1089 - 1097
Neonatal syphilis: clinical and laboratory assessments and postnatal treatments for infants born to infected mothers Nursel Atay ÜnalZeynep Savaş ŞenAyşe Kaman Research 19 February 2025 Pages: 1099 - 1105
Trends in incidence of neonatal late-onset sepsis in very low birth weight infants: a 15-year Brazilian single center analysis Bárbara Barros Pereira LoboJamil Pedro de Siqueira Caldas Research 21 February 2025 Pages: 1107 - 1118
High prevalence and incidence of HSV-2 among people who inject drugs in Hai Phong, Vietnam, and risk factors associated with seroconversion Morgana D’OttaviIlenia ScialabbaJean-Pierre Molès Research Open access 22 February 2025 Pages: 1119 - 1127
Higher target attainment for B-lactam antibiotics in patients with Gram-negative bloodstream infections when four times actual minimum inhibitory concentrations and epidemiological cutoff values are applied compared to clinical breakpoints Ilja Areskog LejbmanGustav TorissonFredrik Sjövall Research Open access 24 February 2025 Pages: 1129 - 1137
Safety of high-dose daptomycin in obese patients: a multicentric retrospective study Vasco Dias MeirelesClémentine AiraudMarin Lahouati Research 24 February 2025 Pages: 1139 - 1146
Is the isolation of S. epidermidis from pre-operative synovial fluid culture a predictor of S. epidermidis prosthetic joint infection? Flaminia OlearoCarl Philipp SchoppmeierHolger Rohde Research Open access 25 February 2025 Pages: 1147 - 1154
Deciphering the genetic context of the emerging OXA-484-producing carbapenem-resistant Escherichia coli from ST167 high-risk clone in the United Arab Emirates Farah Al-MarzooqAkela GhazawiTimothy Collyns Research 28 February 2025 Pages: 1155 - 1166
Diversity of Mycoplasma genitalium strains in Australia: relationship with sexual networks and antimicrobial resistance Teck-Phui ChuaJennifer A. DanielewskiGerald L. Murray Research Open access 03 March 2025 Pages: 1167 - 1175
The feasibility of antimicrobial lead time as process and quality indicator for hospitals R. I. HelouH. van der SijsA. Verbon Research Open access 07 March 2025 Pages: 1177 - 1183
Impact of rapid identification by MALDI-TOF MS from positive blood cultures in Enterococcus spp. bloodstream infections Diogo LopesBruno GrandbastienBenoit Guery Research Open access 08 March 2025 Pages: 1185 - 1196
Determinants of time to positivity in bloodstream infections: an analysis of a population-based cohort in Queensland, Australia Felicity EdwardsMichael WallerKevin B. Laupland Research Open access 08 March 2025 Pages: 1197 - 1204
Voriconazole in the treatment of pediatric patients with hematologic malignancies and invasive fungal infections: a real-world study Namei WuLili CaiZhihang Lin Research 09 March 2025 Pages: 1205 - 1217
Schistosomiasis trends and control efforts: a global perspective from 1990 to 2050 Bahe DongZhiyong HouKeqiang Lu Research 10 March 2025 Pages: 1219 - 1230
Evaluation of imipenem-relebactam susceptibility testing in carbapenem resistant Pseudomonas aeruginosa: comparison of sensititre microplates, disc diffusion, and MTS gradient strips with broth microdilution Adrien BiguenetLéa DevoosKaty Jeannot Research 13 March 2025 Pages: 1231 - 1237
Fulminant parvovirus B19 myocarditis in infants –report of three post-pandemic cases Tatjana WahjudiAlex NitschPeter H. Hoeger Brief Report 17 February 2025 Pages: 1239 - 1243
Successful treatment of carbapenem-resistant Acinetobacter baumannii meningitis and purulent ventriculitis using cefiderocol combination therapy: a case report and literature review Xuan WangQihui LiuNing Li Brief Report 21 February 2025 Pages: 1245 - 1250
Improving effective antimicrobial resistance (AMR) prevention in ambulatory care: lessons from secondary appraisal of Belgian anti-infectious treatment care guidelines Johan Van LaethemSimon PlankenNicolas Dauby Brief Report 24 February 2025 Pages: 1251 - 1263
Genotyping and treatment issues with ‘unusual’ HCV 1 subtypes Cinzia CaudaiPiera PierottiMaurizio Zazzi Brief Report 26 February 2025 Pages: 1265 - 1271
Extensively drug-resistant Haemophilus influenzae isolated in Geneva, Switzerland Abdessalam CherkaouiPatrice FrancoisJacques Schrenzel Brief Report Open access 06 March 2025 Pages: 1273 - 1277
Beta-lactam combination treatment overcomes rifampicin resistance in Mycobacterium tuberculosis Diana H. QuanTrixie WangJan-Willem Alffenaar Brief Report Open access 06 March 2025 Pages: 1279 - 1284
Retraction Note: Variations in respiratory pathogen carriage among a homeless population in a shelter for men in Marseille, France, March–July 2020: cross-sectional 1-day surveys Tran Duc Anh LyVan Thuan HoangPhilippe Gautret Retraction Note 18 February 2025 Pages: 1285 - 1285
Retraction Note: Gastrointestinal symptoms and the acquisition of enteric pathogens in Hajj pilgrims: a 3-year prospective cohort study Van-Thuan HoangThi-Loi DaoPhilippe Gautret Retraction Note 24 February 2025 Pages: 1287 - 1287